William D. Fiske

Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1

Stuart E. Starr, Courtney V. Fletcher, Stephen A. Spector et al. · New England Journal of Medicine · 1999 · 211 citations · Full text

Hepatic but not intestinal CYP3A4 displays dose‐dependent induction by efavirenz in humans

Stéphane Mouly, Kenneth S. Lown, David M. Kornhauser et al. · Clinical Pharmacology & Therapeutics · 2002 · 208 citations · Full text

Cerebrospinal Fluid Human Immunodeficiency Virus Type 1 (HIV‐1) Suppression and Efavirenz Drug Concentrations in HIV‐1–Infected Patients Receiving Combination Therapy

Karen T. Tashima, Angela M. Caliendo, Musfirah Ahmad et al. · The Journal of Infectious Diseases · 1999 · 109 citations · Full text

Pharmacokinetic and Pharmacodynamic Investigation of Efavirenz in the Semen and Blood of Human Immunodeficiency Virus Type 1–Infected Men

Y. Sunila Reddy, S. Karl Gotzkowsky, Joseph J. Eron et al. · The Journal of Infectious Diseases · 2002 · 44 citations

Hiv-1 Rna, Treatment And Prevention, Medicine +12

The Effects of Ethanol on the Bioavailability of Oxymorphone Extended-Release Tablets and Oxymorphone Crush-Resistant Extended-Release Tablets

William D. Fiske, Janet Jobes, Qinfang Xiang et al. · Journal of Pain · 2011 · 35 citations · Full text

Pharmacology, Oxymorphone Extended-release Tablets